June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
RIPLs, an optical coherence tomography marker of occult cardiovascular disease
Author Affiliations & Notes
  • Samantha Madala
    University of California San Diego, La Jolla, California, United States
  • Fatemeh Adabifirouzjaei
    University of California San Diego, La Jolla, California, United States
  • Leonardo Lando
    University of Toronto, Toronto, Ontario, Canada
  • Adeleh Yarmohammadi
    University of California San Diego, La Jolla, California, United States
  • Christopher Long
    University of Southern California, Los Angeles, California, United States
  • Christine Bakhoum
    Yale School of Medicine, New Haven, Connecticut, United States
  • Michael Goldbaum
    University of California San Diego, La Jolla, California, United States
  • David Sarraf
    University of California Los Angeles, Los Angeles, California, United States
  • Anthony DeMaria
    University of California San Diego, La Jolla, California, United States
  • Mathieu Bakhoum
    Yale School of Medicine, New Haven, Connecticut, United States
  • Footnotes
    Commercial Relationships   Samantha Madala None; Fatemeh Adabifirouzjaei None; Leonardo Lando None; Adeleh Yarmohammadi None; Christopher Long None; Christine Bakhoum None; Michael Goldbaum None; David Sarraf Amgen, Code C (Consultant/Contractor), Bayer, Code C (Consultant/Contractor), Iveric Bio, Code C (Consultant/Contractor), Novartis, Code C (Consultant/Contractor), Optovue, Code C (Consultant/Contractor); Anthony DeMaria None; Mathieu Bakhoum None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 1755 – F0215. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Samantha Madala, Fatemeh Adabifirouzjaei, Leonardo Lando, Adeleh Yarmohammadi, Christopher Long, Christine Bakhoum, Michael Goldbaum, David Sarraf, Anthony DeMaria, Mathieu Bakhoum; RIPLs, an optical coherence tomography marker of occult cardiovascular disease. Invest. Ophthalmol. Vis. Sci. 2022;63(7):1755 – F0215.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Cardiovascular disease is the number one cause of death in the world, and frequently goes unnoticed until the occurrence of serious events such as heart attack or stroke. Therefore, early detection of occult cardiovascular disease, prior to catastrophic illness, is critical. We sought to determine whether retinal ischemic perivascular lesions (RIPLs), which are anatomical biomarkers of subclinical microvascular ischemia in the retina, can be used to detect occult cardiovascular disease.

Methods : We identified individuals with no significant retinal pathologies and who had RIPLs detected on spectral domain optical coherence tomography (SD-OCT) scans during routine retinal examination in our clinic. We excluded individuals with pre-existing cardiovascular disease, diabetes, and those who did not have a follow-up medical visit. Additionally, we excluded patients with any retinal pathology including diabetic retinopathy. We reviewed the medical chart and present the medical outcome of subjects who had subsequent cardiovascular workup prompted by RIPLs detection.

Results : We identified thirty-six patients, with incidental RIPL identification on SD-OCT at the time of examination. A total of 25 patients were excluded. Of the 11 subjects that were included, 5 were males and 6 were females. Ages ranged from 44 to 80 years. The eleven subjects with no prior history of cardiovascular disease, other than essential HTN, followed up with their primary care physician or cardiologist for age-appropriate cardiovascular work-up. Of these, newly diagnosed cardiovascular disease was identified in 8 individuals (72.7%), including three-vessel CAD, significant carotid artery stenosis, soft carotid plaque, reduced cardiac ejection fraction, patent foramen ovale, cerebral infarction, subclavian steal syndrome and undiagnosed or uncontrolled HTN. Two patients subsequently underwent invasive procedures including coronary artery bypass grafting (CABG) and carotid artery stent placement. Three patients were started on new medical therapy for their conditions, and two were advised to undergo periodic follow up.

Conclusions : Our findings indicate that presence of RIPLs, which are anatomical markers of prior retinal ischemic infarcts, may indicate the need for cardiovascular referral which in some cases can lead to important interventional management.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×